Pfizer has stopped developing a drug for obesity

World 06:36, 15-04-2025

127

Pfizer has stopped work on the obesity drug Danuglipron, according to bloomberg.com. The reason is that a serious liver-related adverse effect was identified in one participant during clinical trials.

With this decision, the company may halt competition with market leaders in weight-loss drugs — Novo Nordisk and Eli Lilly. Pfizer will not conduct the final phase of trials and will focus on early-stage solutions for obesity.

According to Bloomberg, Pfizer, which made significant profits during the COVID-19 pandemic, was looking to actively engage in the weight loss market. This sector is expected to reach $130 billion by 2030.

Nodirbek Razzokov

Muxbir

Similar news

Artificial intelligence misled the court with forged documents

Although technological advancements make our lives easier, they sometimes bring unexpected problems. This was reported by Zamin.uz. An incident in India serves as an example. Fake documents created

World Today, 10:14

Complexities in the Middle East: Iranian Strikes and Arab Silence

The situation in the Middle East is becoming increasingly complex. This was reported by Zamin.uz. The weak reaction of some Arab countries in the region to Iranian strikes is surprising many. Not

World Today, 09:41

Conflict Intensity Increasing in the Middle East, Iran Ready for Test

The situation in the Middle East is currently very complex. This was reported by Zamin.uz. The events that will occur within the next 24 hours will determine the direction of the conflict's

World Today, 09:28

The "Lahta-2" and "Lahta-3" projects have been submitted for expert review

The planning and delimitation project for the construction of the "Laxta-2" and "Laxta-3" skyscrapers has been submitted for anti-corruption expertise, reports "RBK

World Today, 07:32

Trump's Statement Increased Tensions in the Middle East

US President Donald Trump's recent statement has further complicated the situation in the Middle East. This was reported by Zamin.uz. According to him, another strong blow has been dealt to the

World Today, 01:34

An expensive medicine was provided to a child in Krasnodar

A child living in Krasnodar has already been provided with expensive medicine worth 245 million rubles, but the second medicine is not registered in Russia. This was reported by Zamin.uz. The child

World Yesterday, 23:34